Microbot Medical Inc (MBOT) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Microbot Medical Inc   (NASDAQ: MBOT)
 

Microbot Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Microbot Medical Inc inventory turnover ratio, the Microbot Medical Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.69 in the second quarter 2026, MBOT's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Microbot Medical Inc in Jun 30 2026 quarter, has decreased to 529 days, compare to 2433 days, in the Mar 31 2026 quarter.

Within Healthcare sector Microbot Medical Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

MBOT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Microbot Medical Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MBOT Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.69 0.15 - - -
MBOT's Total Ranking # # # # #
Average inventory processing period 531 2517 - - -
Seq. Inventory Growth 28.8 % 286.47 % - - -
Seq. Cost of Sales Growth 758.25 % - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



MBOT Company Profile >> Back to MBOT Efficiency Comparisons >> Compare MBOT Inventory Turnover Ratio to its Competitors

Financial Statements
Microbot Medical Inc 's Inventories $ 3 Millions Visit MBOT's Balance sheet
Microbot Medical Inc 's Cost of Revenues TTM $ 1 Millions Visit MBOT's Income Statement
What are MBOT's Sales? Visit MBOT's Sales by Segment

Other Inventory Turnover Ratios
Microbot Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MBOT's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MBOT's Competitors
Inventory Turnover Ratio for MBOT's Suppliers
Inventory Turnover Ratio for MBOT's Customers

You may also want to know
MBOT's Sales Growth Rates MBOT's Pe Price to earnings ratio MBOT's Receivables Turnover Ratio MBOT's Stock Quote
MBOT's Net Income Growth Rates MBOT's Ps Price to Sales ratio MBOT's Sales per Employee MBOT's Asset Turnover Ratio
MBOT's Net Margin MBOT's Pb Price to Book ratio MBOT's Financial Strength Ratios MBOT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Protalix Biotherapeutics inc   0.91 $ 24.832  Millions$ 27  Millions
Igc Pharma Inc   0.90 $ 0.745  Millions$ 1  Millions
Neurocrine Biosciences Inc   0.89 $ 68.600  Millions$ 77  Millions
Maxcyte inc   0.84 $ 6.450  Millions$ 8  Millions
Establishment Labs Holdings Inc   0.83 $ 71.831  Millions$ 86  Millions
Adma Biologics Inc   0.83 $ 179.465  Millions$ 216  Millions
Tonix Pharmaceuticals Holding Corp   0.83 $ 4.706  Millions$ 6  Millions
Petvivo Holdings Inc   0.83 $ 0.390  Millions$ 0  Millions
Profound Medical Corp   0.81 $ 5.385  Millions$ 7  Millions
Beone Medicines Ltd   0.79 $ 506.000  Millions$ 639  Millions
Blue Water Vaccines Inc  0.78 $ 0.127  Millions$ 0  Millions
Milestone Scientific Inc   0.77 $ 2.804  Millions$ 4  Millions
Sensus Healthcare Inc   0.76 $ 11.924  Millions$ 16  Millions
Nuvation Bio Inc   0.76 $ 10.000  Millions$ 13  Millions
Lexicon Pharmaceuticals Inc   0.75 $ 0.358  Millions$ 0  Millions
Picard Medical Inc   0.71 $ 4.811  Millions$ 7  Millions
Immunocore Holdings Plc  0.67 $ 4.738  Millions$ 7  Millions
Gyre Therapeutics Inc   0.65 $ 6.807  Millions$ 10  Millions
Liquidia Corporation  0.64 $ 18.181  Millions$ 28  Millions
Bioxcel Therapeutics Inc   0.64 $ 0.348  Millions$ 1  Millions
Envoy Medical Inc   0.64 $ 1.005  Millions$ 2  Millions
X4 Pharmaceuticals Inc  0.63 $ 2.930  Millions$ 5  Millions
Organogenesis Holdings Inc   0.62 $ 19.764  Millions$ 32  Millions
Xeris Biopharma Holdings Inc   0.62 $ 45.029  Millions$ 73  Millions
Lenz Therapeutics Inc   0.62 $ 1.774  Millions$ 3  Millions
Jaguar Health Inc   0.57 $ 4.921  Millions$ 9  Millions
Travere Therapeutics Inc   0.57 $ 8.263  Millions$ 14  Millions
Cvrx inc   0.57 $ 6.981  Millions$ 12  Millions
Biomarin Pharmaceutical Inc  0.57 $ 813.588  Millions$ 1,434  Millions
Verastem Inc   0.54 $ 1.128  Millions$ 2  Millions

Date modified: 2026-09-08T18:50:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.